| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0071 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |